Icon

SYNDROS (nda205525)- (5MG/ML)

DRONABINOL BENUVIA OPERATIONS
5MG/ML
Yes Yes
2028-Aug-06 Expired
None None
None No
SYNDROS is a cannabinoid indicated in adults for the treatment of: • anorexia associated with weight loss in patients with AIDS. • nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
0 0 0
Total Other Developers None
Drugs with Suitability No
5MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.